Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706
International Journal of Molecular Sciences · 19.05.2025 · 26 (10) · 4837
DOI: 10.3390/ijms26104837 ↗Kurz gefasst
Korrektur in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.05.2025. Verfasst von I-Chang Su und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Council of Taiwan, Taipei Medical University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
In the original publication [...]
Autor:innen und Institutionen
- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan.
- Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan.
- Division of Neurosurgery, Department of Surgery, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan.
- Taipei Neuroscience Institute, Taipei Medical University, Taipei City 11031, Taiwan.
- International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei City 11031, Taiwan.
- Department of Medical Research & Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City 23561, Taiwan.
ORCID-Profile: Syahru Agung Setiawan, Vijesh Kumar Yadav, Iat-Hang Fong, Chi-Tai Yeh, Chien-Min Lin
Förderung
- National Science Council of Taiwan
- Taipei Medical University
Zitieren
APA
Su, I. C., Su, Y. K., Setiawan, S. A., Yadav, V. K., Fong, I. H., Yeh, C. T., Lin, C. M., & Liu, H. W. (2025). Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706. International Journal of Molecular Sciences, 26(10), 4837. https://doi.org/10.3390/ijms26104837
Vancouver
Su IC, Su YK, Setiawan SA, Yadav VK, Fong IH, Yeh CT, et al. Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706. International Journal of Molecular Sciences. 2025;26(10):4837. doi:10.3390/ijms26104837
BibTeX
@article{Su2025,
author = {Su, I-Chang and Su, Yu-Kai and Setiawan, Syahru Agung and Yadav, Vijesh Kumar and Fong, Iat-Hang and Yeh, Chi-Tai and Lin, Chien-Min and Liu, Heng-Wei},
title = {Correction: Su et al. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation. Int. J. Mol. Sci. 2023, 24, 7706},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {10},
pages = {4837},
doi = {10.3390/ijms26104837}
}
EUVIMED